Cargando…

Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction

BACKGROUND: Helicobacter pylori infection and interleukin-1 polymorphisms are associated with an increased risk of gastric cancer. We examined the prevalence of Helicobacter pylori seropositivity and interleukin-1 polymorphisms between ST-segment elevation myocardial infarction and non-ST-segment el...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabata, Noriaki, Sueta, Daisuke, Akasaka, Tomonori, Arima, Yuichiro, Sakamoto, Kenji, Yamamoto, Eiichiro, Izumiya, Yasuhiro, Yamamuro, Megumi, Tsujita, Kenichi, Kojima, Sunao, Kaikita, Koichi, Morita, Kazunori, Oniki, Kentaro, Saruwatari, Junji, Nakagawa, Kazuko, Hokimoto, Seiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104372/
https://www.ncbi.nlm.nih.gov/pubmed/27832202
http://dx.doi.org/10.1371/journal.pone.0166240
_version_ 1782466732504383488
author Tabata, Noriaki
Sueta, Daisuke
Akasaka, Tomonori
Arima, Yuichiro
Sakamoto, Kenji
Yamamoto, Eiichiro
Izumiya, Yasuhiro
Yamamuro, Megumi
Tsujita, Kenichi
Kojima, Sunao
Kaikita, Koichi
Morita, Kazunori
Oniki, Kentaro
Saruwatari, Junji
Nakagawa, Kazuko
Hokimoto, Seiji
author_facet Tabata, Noriaki
Sueta, Daisuke
Akasaka, Tomonori
Arima, Yuichiro
Sakamoto, Kenji
Yamamoto, Eiichiro
Izumiya, Yasuhiro
Yamamuro, Megumi
Tsujita, Kenichi
Kojima, Sunao
Kaikita, Koichi
Morita, Kazunori
Oniki, Kentaro
Saruwatari, Junji
Nakagawa, Kazuko
Hokimoto, Seiji
author_sort Tabata, Noriaki
collection PubMed
description BACKGROUND: Helicobacter pylori infection and interleukin-1 polymorphisms are associated with an increased risk of gastric cancer. We examined the prevalence of Helicobacter pylori seropositivity and interleukin-1 polymorphisms between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients. METHODS: We recruited consecutive acute coronary syndrome patients, and 101 non-ST-segment elevation acute coronary syndrome patients and 103 ST-segment elevation myocardial infarction patients were enrolled. Interleukin-1 polymorphism analyses were performed for single nucleotide polymorphism in interleukin-1 beta-511 and the variable number of tandem repeats polymorphism in the interleukin-1 receptor antagonist by polymerase chain reaction. Immunoglobulin G antibodies against Helicobacter pylori and high sensitivity C-reactive protein were also measured. RESULTS: The rates of the simultaneous presence of interleukin-1 polymorphisms and Helicobacter pylori-seropositivity between non-ST-segment elevation acute coronary syndrome and ST-segment elevation myocardial infarction groups were 25.7% and 42.7%, respectively (P = 0.012). Helicobacter pylori-seropositive subjects with interleukin-1 polymorphisms showed significantly higher levels of high sensitivity C-reactive protein (0.04–0.12 vs. 0.02–0.05; P<0.001). Multivariate logistic regression analysis revealed that the carriage of Helicobacter pylori-seropositivity and interleukin-1 polymorphisms was significantly associated with ST-segment elevation myocardial infarction (odds ratio, 2.32; 95% confidence interval, 1.23–4.37; P = 0.009). The C-statistic of conventional risk factors was 0.68 (P<0.001) and that including Helicobacter pylori-seropositivity and interleukin-1 polymorphisms was 0.70 (P<0.001); continuous net reclassification improvement was 34% (P = 0.0094) and integrated discrimination improvement was 3.0% (P = 0.014). CONCLUSIONS: The coincidence of Helicobacter pylori-seropositivity and interleukin-1 polymorphisms was significantly associated with higher levels of high sensitivity C-reactive protein and the increased risk of ST-segment elevation myocardial infarction.
format Online
Article
Text
id pubmed-5104372
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51043722016-12-08 Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction Tabata, Noriaki Sueta, Daisuke Akasaka, Tomonori Arima, Yuichiro Sakamoto, Kenji Yamamoto, Eiichiro Izumiya, Yasuhiro Yamamuro, Megumi Tsujita, Kenichi Kojima, Sunao Kaikita, Koichi Morita, Kazunori Oniki, Kentaro Saruwatari, Junji Nakagawa, Kazuko Hokimoto, Seiji PLoS One Research Article BACKGROUND: Helicobacter pylori infection and interleukin-1 polymorphisms are associated with an increased risk of gastric cancer. We examined the prevalence of Helicobacter pylori seropositivity and interleukin-1 polymorphisms between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients. METHODS: We recruited consecutive acute coronary syndrome patients, and 101 non-ST-segment elevation acute coronary syndrome patients and 103 ST-segment elevation myocardial infarction patients were enrolled. Interleukin-1 polymorphism analyses were performed for single nucleotide polymorphism in interleukin-1 beta-511 and the variable number of tandem repeats polymorphism in the interleukin-1 receptor antagonist by polymerase chain reaction. Immunoglobulin G antibodies against Helicobacter pylori and high sensitivity C-reactive protein were also measured. RESULTS: The rates of the simultaneous presence of interleukin-1 polymorphisms and Helicobacter pylori-seropositivity between non-ST-segment elevation acute coronary syndrome and ST-segment elevation myocardial infarction groups were 25.7% and 42.7%, respectively (P = 0.012). Helicobacter pylori-seropositive subjects with interleukin-1 polymorphisms showed significantly higher levels of high sensitivity C-reactive protein (0.04–0.12 vs. 0.02–0.05; P<0.001). Multivariate logistic regression analysis revealed that the carriage of Helicobacter pylori-seropositivity and interleukin-1 polymorphisms was significantly associated with ST-segment elevation myocardial infarction (odds ratio, 2.32; 95% confidence interval, 1.23–4.37; P = 0.009). The C-statistic of conventional risk factors was 0.68 (P<0.001) and that including Helicobacter pylori-seropositivity and interleukin-1 polymorphisms was 0.70 (P<0.001); continuous net reclassification improvement was 34% (P = 0.0094) and integrated discrimination improvement was 3.0% (P = 0.014). CONCLUSIONS: The coincidence of Helicobacter pylori-seropositivity and interleukin-1 polymorphisms was significantly associated with higher levels of high sensitivity C-reactive protein and the increased risk of ST-segment elevation myocardial infarction. Public Library of Science 2016-11-10 /pmc/articles/PMC5104372/ /pubmed/27832202 http://dx.doi.org/10.1371/journal.pone.0166240 Text en © 2016 Tabata et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Tabata, Noriaki
Sueta, Daisuke
Akasaka, Tomonori
Arima, Yuichiro
Sakamoto, Kenji
Yamamoto, Eiichiro
Izumiya, Yasuhiro
Yamamuro, Megumi
Tsujita, Kenichi
Kojima, Sunao
Kaikita, Koichi
Morita, Kazunori
Oniki, Kentaro
Saruwatari, Junji
Nakagawa, Kazuko
Hokimoto, Seiji
Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction
title Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction
title_full Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction
title_fullStr Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction
title_full_unstemmed Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction
title_short Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction
title_sort helicobacter pylori seropositivity in patients with interleukin-1 polymorphisms is significantly associated with st-segment elevation myocardial infarction
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104372/
https://www.ncbi.nlm.nih.gov/pubmed/27832202
http://dx.doi.org/10.1371/journal.pone.0166240
work_keys_str_mv AT tabatanoriaki helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction
AT suetadaisuke helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction
AT akasakatomonori helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction
AT arimayuichiro helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction
AT sakamotokenji helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction
AT yamamotoeiichiro helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction
AT izumiyayasuhiro helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction
AT yamamuromegumi helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction
AT tsujitakenichi helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction
AT kojimasunao helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction
AT kaikitakoichi helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction
AT moritakazunori helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction
AT onikikentaro helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction
AT saruwatarijunji helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction
AT nakagawakazuko helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction
AT hokimotoseiji helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction